We are live on ! Find out more
MDNA

Medicenna Therapeutics Corp. Common Shares
MDNA

Delisted

MDNA was delisted on the 1st of November, 2023.

Back to rankings

Fund managers haven’t disclosed any holdings of MDNA yet.

MDNA Hedge Fund Activity: Q1 2025 in Review

0 of the 7,459 institutional investors tracked by Wall St. Rank reported a position in Medicenna Therapeutics Corp. Common Shares (MDNA) for Q1 2025, worth a combined $0 — down 100% from $200K a quarter earlier.

Sellers outnumbered buyers: 1 fund closed out of MDNA and 0 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest seller was ORG Partners, exiting entirely with an estimated $200K sold.

  • 0 institutional investors held Medicenna Therapeutics Corp. Common Shares (MDNA) as of Q1 2025, down from 1 in Q4 2024.
  • Funds reported $0 of Medicenna Therapeutics Corp. Common Shares stock for Q1 2025, down 100% quarter-over-quarter.
  • 0 funds opened new Medicenna Therapeutics Corp. Common Shares positions in Q1 2025 and 1 closed out, a net change of -1 holder.
  • The largest Medicenna Therapeutics Corp. Common Shares seller in Q1 2025 was ORG Partners, an estimated $200K sold.

Based on aggregated 13F filings for Q1 2025.